Mast cell contribution to tumor angiogenesis: A clinical approach

European Cytokine Network

Volumn 20, Issue 4, 2009, Pages 197-206

  Crivellato, Enrico ^a   Nico, Beatrice ^b   Ribatti, Domenico ^b  

^a UNIVERSITY OF UDINE   (Italy)

^b UNIVERSITY OF BARI MEDICAL SCHOOL   (Italy)

Author keywords

Mast cells; Tumor angiogenesis

Indexed keywords

CHEMOKINE; CYTOKINE; GROWTH FACTOR; VASCULOTROPIN;

ACUTE GRANULOCYTIC LEUKEMIA; ANGIOGENESIS; B CELL LEUKEMIA; B CELL LYMPHOMA; BONE MARROW BIOPSY; BREAST CANCER; CANCER PATIENT; CARCINOGENESIS; CELL DENSITY; CELL FUNCTION; CELL GROWTH; CELL MIGRATION; CELL PROLIFERATION; CELL TYPE; CHRONIC LYMPHATIC LEUKEMIA; COLORECTAL CARCINOMA; CYTOKINE RELEASE; CYTOLOGY; DEGRANULATION; DISEASE COURSE; DISEASE SEVERITY; ELECTRON MICROSCOPY; EXOCYTOSIS; HEMATOLOGIC MALIGNANCY; HUMAN; INFLAMMATION; LUNG NON SMALL CELL CANCER; LYMPHATIC LEUKEMIA; MAST CELL; MEDIATOR; MULTIPLE MYELOMA; MYELODYSPLASTIC SYNDROME; NONHODGKIN LYMPHOMA; NONHUMAN; OUTCOME ASSESSMENT; PATHOLOGY; PATHOPHYSIOLOGY; PROGNOSIS; REVIEW; SOLID TUMOR; TUMOR ASSOCIATED LEUKOCYTE; UTERINE CERVIX CARCINOMA; VASCULARIZATION;

ANIMALS; HUMANS; INFLAMMATION; MAST CELLS; NEOPLASMS; NEOVASCULARIZATION, PATHOLOGIC;

EID: 72249089192     PISSN: 11485493     EISSN: None     Source Type: Journal    
DOI: 10.1684/ecn.2009.0167     Document Type: Review

References (110)

1. Ehrlich P. Beiträge zur Theorie und Praxis der Histologischen Färbung. Thesis, Leipzig University, 1878.
2. Gurish MF, Austen KF. The diverse role of mast cells. J Exp Med 2001; 194: 1-5.
3. Levi-Schaffer F, Austen KF, Gravallese PM, Stevens RL. Coculture of interleukin 3-dependent mouse mast cells with fibroblasts results in a phenotypic change of mast cells. Proc Natl Acad Sci USA 1986; 63: 6485-6488 (Pubitemid 17174759)
4. Gurish MF, Boyce JA. Mast cells: ontogeny, homing, and recruitment of a unique innate effector cell. J Allergy Clin Immunol 2006; 117: 1285-1291
5. Heib V, Becker M, Taube C, Stassen M. Advances in the understanding of mast cell function. Brit J Haematol 2008 in press.
6. Irani AM, Schwartz LB. Human mast cell heterogeneity. Allergy and Asthma Proceedings 1994; 15: 303-308
7. Galli SJ, Tsai M. Mast cells: Versatile regulators of inflammation, tissue remodeling, host defence and homeostasis. J Dermatol Sci 2008; 49: 7-19. (Pubitemid 350236713)
8. Gilfillan AM, Tkaczyk C. Integrated signalling pathways for mast cell activation. Nature Review Immunology 2006; 6: 218-230 (Pubitemid 43290991)
9. Sayed BA, Christy A, Quirion MR, Brown MA. The master switch: the role of mast cells in autoimmunity and tolerance. Annu Rev Immunol 2008; 26: 705-739 (Pubitemid 351600390)
10. Metz M, Grimbaldeston MA, Nakae S, Piliponsky AM, Tsai M, Galli SJ. Mast cells in promotion and limitation of chronic inflammation. Immunol Rev 2007; 217: 304-328 (Pubitemid 46718153)
11. Echtenacher B, Männel DN, Hültner L. Critical protective role of mast cells in a model of acute septic peritonitis. Nature 1996; 381: 75-77 (Pubitemid 26130005)
12. Malaviya R, Ikeda T, Ross E, Abraham SN. Mast cell modulation of neutrophil influx and bacterial clearance at sites of infection through TNF-α. Nature 1996; 381: 77-80. (Pubitemid 26130006)
13. Metz M, Siebenhaar F, Maurer M. Mast cell functions in the innate skin immune system. Immunobiology 2008; 213: 251-260
14. Benoist C, Mathis D. Mast cells in autoimmune disease. Nature 2002; 420: 875-878
15. Dvorak AM. Basophil and mast cell degranulation and recovery. In: Harris JR, ed. Blood Cell Biochemistry. New York: Plenum Press, 1991: 340-377
16. Crivellato E, Nico B, Vacca A, Dammacco F, Ribatti D. Mast cell heterogeneity in B-cell non-Hodgkin's lymphomas: an ultrastructural study. Leuk Lymphoma 2002; 43: 2201-2205 (Pubitemid 35174734)
17. Theoharides TC, Kempuraj D, Tagen M, Conti P, Kalogeromitros D. Differential release of mast cell mediators and the pathogenesis of inflammation. Immunol Rev 2007; 217: 65-78. (Pubitemid 46718152)
18. Risau W. Mechanisms of angiogenesis. Nature 1997; 386: 671-674
19. Ribatti D. Genetic and epigenetic mechanisms in the early development of the vascular system. Journal of Anatomy 2006; 208: 139-152 (Pubitemid 43362009)
20. Burri PH, Djonov D. Intussusceptive angiogenesis - the alternative to capillary sprouting. Mol Aspects Med 2002; 23: S1-27.
21. Puxeddu I, Ribatti D, Crivellato E, Levi-Schaffer F. Mast cells and eosinophils: a novel link between inflammation and angiogenesis in allergic diseases. J Allergy Clin Immunol 2005; 116: 531-536 (Pubitemid 41267124)
22. Folkman J. Angiogenesis in cancer, vascular rheumatoid and other disease. Nat Med 1995; 1: 27-31.
23. Ribatti D, Vacca A, Dammacco F. The role of vascular phase in solid tumor growth: a historical review. Neoplasia 1999; 1: 293-302.
24. Vacca A, Ribatti D. Bone marrow angiogenesis in multiple myeloma. Leukemia 2006; 20: 193-199 (Pubitemid 43148652)
25. Folkman J. What is the role of endothelial cells in angiogenesis? Lab Invest 1984; 51: 601-604
26. Folkman J, Watson K, Ingber D, Hanahan D. Induction of angiogenesis during the transition from hyperplasia to neoplasia. Nature 1989; 339: 58-61. (Pubitemid 19115892)
27. Ribatti D, Nico B, Crivellato E, Roccaro AM, Vacca A. The history of the angiogenic switch concept. Leukemia 2007; 21: 44-52.
28. Ribatti D, Nico B, Crivellato E, Vacca A. The structure of the vascular network in tumors. Cancer Lett 2007; 248: 18-23.
29. Norrby K. Mast cells and angiogenesis. APMIS 2002; 110: 355-371
30. Qu Z, Liebler JM, Powers MR, et al. Mast cells are a major source of basic fibroblast growth factor in chronic inflammation and cutaneous hemangioma. Am J Pathol 1995; 147: 564-573
31. Qu Z, Huang X, Ahmadi P, et al. Synthesis of basic fibroblast growth factor by murine mast cells. Regulation by transforming growth factor beta, tumor necrosis factor alpha, and stem cell factor. Int Arch Allergy Immunol 1998; 115: 47-54.
32. Qu Z, Kayton RJ, Ahmadi P, et al. Ultrastructural immunolocalization of basic fibroblast growth factor in mast cell secretory granules. Morphological evidence for bfgf release through degranulation. J Histochem Cytochem 1998; 46: 1119-1128 (Pubitemid 28445286)
33. Grutzkau A, Kruger-Krasagakes S, Baumesteir H, et al. Synthesis, storage, and release of vascular endothelial growth factor/vascular permeability factor (VEGF/VPF) by human mast cells: implications for the biological significance of VEGF 206. Molecular Biology of the Cell 1998; 9: 875-884 (Pubitemid 28173640)
34. Abdel-Majid RM, Marshall JS. Prostaglandin E2 induces degranulation-independent produxtion of vascular endothelial growth factor by human mast cells. J Immunol 2004; 172: 1227-1236 (Pubitemid 38113786)
35. Cao L, Curtis CL, Theoharides TC. Corticotropin-releasing hormone induces vascular endothelial growth factor release from human mast cells via the cAMP/protein kinase A/p38 mitogen activate protein kinase pathway. Mol Pharmacol 2006; 69: 998-1006.
36. Ribatti D, Crivellato E, Candussio L, et al. Mast cells and their secretory granules are angiogenic in the chick embryo chorioallantoic membrane. Clin Exp Allergy 2001; 31: 602-608 (Pubitemid 34204285)
37. Norrby K, Jakobsson A, Sörbo J. Mast cell-mediated angiogenesis: a novel experimental model using the rat mesentery. Virchows Archiv B 1986; 52: 195-206. (Pubitemid 17234474)
38. Norrby K, Jakobsson A, Sörbo J. Mast-cell secretion and angiogenesis, a quantitative study in rats and mice. Virchows Archiv B 1989; 57: 251-256 (Pubitemid 19185647)
39. Metcalfe DD, Baram D, Mekori YA. Mast cells. Physiol Rev 1997; 77: 1033-1079
40. Blair RJ, Meng H, Marchese MJ, Ren S, Schwartz LB, Tonnesen MG. Human mast cells stimulate vascular tube formation: tryptase is a novel potent angiogenic factor. J Clin Invest 1997; 99: 2691-2700 (Pubitemid 27259816)
41. Muramatsu M, Katada J, Hayashi I, Majima M. Chymase as a proangiogenic factor. A possibile involvement of chymase-angiotensin-dependent pathway in hamster sponge angiogenesis model. J Biol Chem 2000; 275: 5545-5552 (Pubitemid 30115190)
42. Kanbe N, Tanaka A, Kanbe M, Itakura A, Kurosawa M, Matsuda H. Human mast cells produce matrix metalloproteinase 9. Eur J Immunol 1999; 29: 2645-2649 (Pubitemid 29378135)
43. Ribatti D, Roncali L, Nico B, Bertossi M. Effects of exogenous heparin on the vasculogenesis of the chorioallantoic membrane. Acta Anat (Basel) 1987; 130: 257-263
44. Sörbo J, Jakobson A, Norrby K. Mast cell histamine is angiogenic through receptors for histamine 1 and histamine 2. Int J Exp Pathol 1994; 75: 43-50. (Pubitemid 24197569)
45. Cantarella G, Lempereur L, Presta M, et al. Nerve growth factor-endothelial cell interaction leads to angiogenesis in vitro and in vivo. FASEB Journal 2002; 16: 1307-1309
46. Ribatti D, Nico B, Belloni AS, Vacca A, Roncali L, Nussdorfer GG. Angiogenic activity of leptin in the chick embryo chorioallantoic membrane is in part mediated by endogenous fibroblast growth factor-2. Int J Mol Med 2001; 8: 265-268
47. Sierra-Honigmann MR, Nath AK, Murakami C, et al. Biological action of leptin as an angiogenic factor. Science 1998; 281: 1683-1686 (Pubitemid 28435586)
48. Meininger CJ, Brightman SE, Kelly KA, Zetter BR. Increased stem cell factor release by hemangioma-derived endothelial cells. Lab Invest 1995; 72: 48-52.
49. Sillaber C, Baghestanian M, Hofbauser R, et al. Molecular and functional characterization of the urokinase receptor on human mast cells. J Biol Chem 1997; 272: 7824-7832 (Pubitemid 27137340)
50. Meininger CJ, Yano H, Rottapel R, Bernstein A, Zsebo KM, Zetter BR. The c-kit receptor ligand functions as a mast cell chemoattractant. Blood 1992; 79: 58-963.
51. Zudaire E, Martinez A, Garayoa M, et al. Adrenomedullin is a cross-talk molecule that regulates tumor and mast cell function during human carcinogenesis. Am J Pathol 2006; 168: 280-291 (Pubitemid 43062580)
52. Juremalm M, Nilsson G. Chemokine receptor expression by mast cells. Chemical Immunology and Allergy 2005; 87: 130-144 (Pubitemid 43093184)
53. Starkey JR, Crowle PK, Taubenberger S. Mast cell-deficient W/Wv mice exhibit a decreased rate of tumor angiogenesis. Int J Cancer 1988; 42: 48-52. (Pubitemid 18174801)
54. Hartveit F. Mast cells and metachromasia in human breast cancer; their occurrence, significance and consequence; a preliminary report. J Pathol 1981; 134: 7-11. (Pubitemid 11104666)
55. Bowrey P, King J, Magarey C, et al. Histamine, mast cells and tumour cell proliferation in breast cancer: does preoperative cimetidine administration have an effect? Brit J Cancer 2000; 82: 167-170
56. Kankkunen JP, Harvima IT, Naukkarinen A. Quantitative analysis of tryptase and chymase containing mast cells in benign and malignant breast lesions. Int J Cancer 1997; 72: 385-388 (Pubitemid 27325861)
57. Thorense S, Tangen M, Hartveit F. Mast cells in the axillary nodes of breast cancer patients. Diagnostic Histopathology 1982; 5: 65-67 (Pubitemid 12182270)
58. Ribatti D, Finato N, Crivellato E, et al. Angiogenesis and mast cells in human breast cancer sentinel lymph nodes with and without micrometastasis. Histopathology 2007; 51: 837-842 (Pubitemid 350179407)
59. Aaltomaa S, Lipponen P, Papinaho S, Kosma VM. Mast cells in breast cancer. Anticancer Res 1993; 13: 785-788
60. Dabiri S, Huntsman D, Makretsov N, et al. The presence of stromal mast cells identifies a subset of invasive breast cancers with a favourable prognosis. Mod Pathol 2004; 17: 690-695 (Pubitemid 38715492)
61. Acikalin MF, Oner U, Topcu I, Yasar B, Kiper H, Colak E. Tumour angiogenesis and mast cell density in the prognostic assessment of colorectal carcinomas. Dig Liver Dis 2005; 37: 162-169 (Pubitemid 41070534)
62. Gulubova M, Vlaykova T. Prognostic significance of mast cell number and microvascular density for the survival of patients with primary colorectal cancer. J Gastroenterol Hepatol 2009; 24: 1265-1275
63. Benitez-Bribiesca L, Wong A, Utrera D, Castellanos E. The role of mast cell tryptase in neoangiogenesis of premalignant and malignant lesions of the uterine cervix. J Histochem Cytochem 2001; 49: 1061-1062 (Pubitemid 32675015)
64. Cabanillas-Saez A, Schalper JA, Nicovani SM, Rudolph MI. Characterization of mast cells according to their content of tryptase and chymase in normal and neoplastic human uterine cervix. Int J Gynecol Cancer 2002; 12: 92-98 (Pubitemid 34202956)
65. Ribatti D, Finato N, Crivellato E, et al. Neovascularization and mast cells with tryptase activity increase simultaneously with pathological progression in human endometrial cancer. Am J Obstet Gynecol 2005; 193: 1961-1965 (Pubitemid 41737619)
66. Iurlaro M, Loverro G, Vacca A, et al. Angiogenesis extent and expression of matrix metalloproteinases-2 and -9 correlate with upgrading and myometrial invasion in endometrial carcinoma. Eur J Clin Invest 1999; 22: 793-801. (Pubitemid 29425521)
67. Ribatti D, Belloni AS, Nico B, et al. Tryptase- and lepti-positive mast cells correlate with vascular density in uterine leiomyomas. Am J Obstet Gynecol 2007; 196: 470-477
68. Zhu XQ, Lv JQ, Lin Y, Xiang M, Gao BH, Shi YF. Expression of chemokines CCL5 and CCL11 by smooth muscle tumor cells of the uterus and its possible role in the recruitment of mast cells. Gynecol Oncol 2007; 105: 650-656 (Pubitemid 46734186)
69. Kumasaka T, Mitani K, Shiotsu H, Kato H, Joho M, Suda K. Vascular endothelial growth factor expressed by mast cells rather than tumour cells in angiomyofibroblastoma of the vascular wall. Histopathology 2007; 51: 557-559 (Pubitemid 47437840)
70. Sawatsubashi M, Yamada T, Fukushima N, Mizokami H, Tokunaga O, Shin T. Association of vascular endothelial growth factor and mast cells with angiogenesis in laryngeal squamous cell carcinoma. Virchows Archiv B 2000; 436: 243-248 (Pubitemid 30168683)
71. Takanami I, Takeuchi K, Narume M. Mast cell density is associated with angiogenesis and poor prognosis in pulmonary adenocarcinoma. Cancer 2000; 88: 2686-2692 (Pubitemid 30417928)
72. Tomita M, Matsuzaki Y, Onitsuka T. Effect of mast cells on tumor angiogenesis in lung cancer. Ann Thorac Surg 2000; 69: 1686-1689
73. Nagata M, Shijubo N, Walls AF, Ichimiya S, Abe S, Sato N. Chymase-positive mast cells in small sized adenocarcinoma of the lung. Virchows Archiv 2003; 443: 565-573
74. Ibaraki T, Muramatsu M, Takai S, et al. The relationship of tryptase- and chymase-positive mast cells to angiogenesis in stage I non-small cell lung cancer. Eur J Cardiothorac Surg 2005; 28: 617-621 (Pubitemid 41345254)
75. Tataroglu C, Kargi A, Özkal S, Esrefoglu N, Akkoclu A. Association of macrophages, mast cells and eosinophil leukocytes with angiogenesis and tumor stage in non-small cell lung carcinomas (NSCLC). Lung Cancer 2004; 43: 47-54. (Pubitemid 38096291)
76. Yano H, Kinuta M, Tateishi H, et al. Mast cell infiltration around gastric cancer cells correlates with tumor angiogenesis and metastasis. Gastric Cancer 1999; 2: 26-32.
77. Kondo K, Muramatsu M, Okamoto Y, et al. Expression of chymase-positive cells in gastric cancer and its correlation with the angiogenesis. J Surg Oncol 2006; 93: 36-43. (Pubitemid 43038424)
78. Esposito I, Menicagli M, Funel N, et al. Inflammatory cells contribute to the generation of an angiogenic phenotype in pancreatic ductal adenocarcinoma. J Clin Pathol 2004; 57: 630-636 (Pubitemid 38725766)
79. Peng SH, Deng H, Yang JF, et al. Significance and relationship between infiltrating inflammatory cells and tumor angiogenesis in hepatocellular carcinoma tissues. World J Gastroenterol 2005; 11: 6521-6524 (Pubitemid 43136892)
80. Zhang Y, Wu XH, Cao GH, Li S. Relationship between expression of matrix metalloproteinase-9 (MMP-9) and angiogenesis in renal cell carcinoma. Ai Zheng 2004; 23: 326-329
81. Tuna B, Yorukoglu K, Unlu M, Mungan MU, Kirkali Z. Association of mast cells with microvessel density in renal cell carcinoma. Eur Urol 2006; 50: 530-534 (Pubitemid 44189044)
82. Ch'ng S, Wallis RA, Yuan L, Davis PF, Tan ST. Mast cells and cutaneous malignancies. Mod Pathol 2006; 19: 149-159
83. Dvorak AM, Mihm Jr MC, Osage JE, Dvorak HF. Melanoma. An ultrastructural study of the host inflammatory and vascular responses. J Invest Dermatol 1980; 75: 388-393
84. Reed JA, McNutt NS, Bogdany JK, Albino AP. Expression of the mast cell growth factor interleukin-3 in the melanocytic lesions correlates with an increased number of mast cells in the perilesional stroma: implications for melanoma progression. J Cutan Pathol 1996; 23: 495-505.
85. Guidolin D, Crivellato E, Nico B, Andreis PG, Nussdorfer GG, Ribatti D. An image analysis of the spatial distribution of perivascular mast cells in human melanoma. Int J Mol Med 2006; 17: 981-987
86. Toth T, Toth-Jakatics R, Jimi S, Takebayashi S, Kawamoto N. Cutaneous malignant melanoma: correlation between neovascularization and peritumoral accumulation of mast cells overexpressing vascular endothelial growth factor. Hum Pathol 2000; 31: 955-960 (Pubitemid 30672616)
87. Ribatti D, Vacca A, Ria R, et al. Neovascularization, expression of fibroblast growth factor-2, and mast cells with tryptase activity increase simultaneously with pathological progression in human malignant melanoma. Eur J Cancer 2003; 39: 666-674 (Pubitemid 36287380)
88. Ribatti D, Ennas MG, Vacca A, et al. Tumor vascularity and tryptase-positive mast cells correlate with a poor prognosis in melanoma. Eur J Clin Invest 2003; 33: 420-425 (Pubitemid 36583711)
89. Elpek GO, Gelen T, Aksoy NH, et al. The prognostic relevance of angiogenesis and mast cells in squamous cell carcinoma of the oesophagus. J Clin Pathol 2001; 54: 940-944 (Pubitemid 34032889)
90. Iamaroon A, Pongsiriwet S, Jittidecharakas S, Pattanaporn K, Prapayasatok S, Wanachantararak S. Increase of mast cells and tumor angiogenesis in oral squamous cell carcinoma. J Oral Pathol Med 2003; 32: 195-199 (Pubitemid 36604013)
91. Ribatti D, Nico B, Maxia C, et al. Neovascularization and mast cells with tryptase activity increase simultaneously in human pterygium. J Cell Mol Med 2007; 11: 585-589 (Pubitemid 47153468)
92. Bertolini F, Mancuso P, Gobbi A, Pruneri G. The thin red line: angiogenesis in normal and malignant hematopoiesis. Exp Hematol 2000; 28: 993-1000.
93. Ribatti D, Vacca A, Nico B, Crivellato E, Roncali L, Dammacco F. The role of mast cells in tumour angiogenesis. Brit J Haematol 2001; 115: 514-521 (Pubitemid 34015640)
94. Ribatti D, Vacca A, Nico B, et al. Bone marrow angiogenesis and mast cell density increase simultaneously with progression of human multiple myeloma. Brit J Cancer 1999; 79: 451-455 (Pubitemid 29046218)
95. Vacca A, Ribatti D, Roncali L, et al. Bone marrow angiogenesis and progression in multiple myeloma. Brit J Haematol 1994; 87: 503-508 (Pubitemid 24230014)
96. Vacca A, Moretti S, Ribatti D, et al. Progression of mycosis fungoides is associated with changes in angiogenesis and expression of the matrix metalloproteinase 2 and 9. Eur J Cancer 1997; 33: 1685-1692 (Pubitemid 28123494)
97. Vacca A, Ribatti D, Presta M, et al. Bone marrow neovascularization, plasma cell angiogenic potential, and matrix metalloproteinase-2 secretion parallel progression of human multiple myeloma. Blood 1999; 93: 3064-3073 (Pubitemid 29200799)
98. Ribatti D, Nico B, Vacca A. Importance of the bone marrow microenvironment in inducing the angiogenic response in multiple myeloma. Oncogene 2006; 25: 4257-4266 (Pubitemid 44100496)
99. Molica S, Vacca A, Ribatti D, et al. Prognostic value of enhanced bone marrow angiogenesis in early B-cell cronica lymphatic leukemia. Blood 2002; 100: 3344-3351 (Pubitemid 35217086)
100. Ribatti D, Molica S, Vacca A, et al. Tryptase-positive mast cells correlate positively with bone marrow angiogenesis in B-cell chronic lymphocytic leukemia. Leukemia 2003; 17: 1428-1430 (Pubitemid 36857360)
101. Molica S, Vacca A, Crivellato E, Cuneo A, Ribatti D. Tryptase-positive mast cells predict clinical outcome of patients with B-cell chronic lymphocytioc leukemia. Eur J Haematol 2003; 71: 137-139 (Pubitemid 36951650)
102. Ribatti D, Polimero G, Vacca A, et al. Correlation of bone marrow angiogenesis and mast cells with tryptase activity in myelodysplastic syndromes. Leukemia 2002; 16: 1680-1684 (Pubitemid 35050097)
103. Ribatti D, Nico B, Vacca A, et al. Do mast cells help to induce angiogenesis in B-cell non-Hodgkin's lymphomas? Brit J Cancer 1998; 77: 1900-1906
104. Ribatti D, Vacca A, Marzullo A, et al. Angiogenesis and mast cell density with tryptase activity increase simultaneously with pathological progression in B-cell non-Hodgkin's lymphomas. Int J Cancer 2000; 85: 171-175 (Pubitemid 30023063)
105. Crivellato E, Nico B, Vacca A, Ribatti D. Ultrastructural analysis of mast cell recovery after secretion by piecemeal degranulation in B-cell non-Hodgkin's lymphoma. Leuk Lymphoma 2003; 44: 517-521 (Pubitemid 36113898)
106. Theoharides TC, Conti P. Mast cells: the Jeckyll and Hyde of tumor growth. Trends Immunol 2004; 25: 235-241 (Pubitemid 38501669)
107. Nico B, Mangieri D, Crivellato E, Vacca A, Ribatti D. Mast cells contribute to vasculogenic mimicry in multiple myeloma. Stem Cells Dev 2008; 17: 19-22. (Pubitemid 351271616)
108. Tan ST, Wallis RA, He Y, Davis PF. Mast cells and hemangioma. Plast Reconstr Surg 2004; 113: 999-1011.
109. Sun ZJ, Zhao YF, Zhao JH. Mast cells in hemangioma: a double-edged sword. Med Hypotheses 2007; 68: 805-807
110. Chan JK, Magistris A, Loizzi V, et al. Mast cell density, angiogenesis, blood clotting, and prognosis in women with advanced ovarian cancer. Gynecol Oncol 2005; 99: 20-25 (Pubitemid 41354578)